News Wire

Positive results have been reported from a pivotal phase 3 study of baricitinib (Eli Lilly/Incyte Corporation), a once-daily oral medication under regulatory review for the treatment of patients with moderate-to-severe rheumatoid arthritis (RA). The study met its primary endpoint of an improved ACR20…
The FDA’s Psychopharmacologic Drugs Advisory Committee has recommended the approval of pimavanserin (Nuplazid, Acadia Pharmaceuticals) for the treatment of psychosis related to Parkinson’s disease (PD). The panel voted 12 to 2 that the drug’s benefits outweigh its risks. Currently, no drugs are…
Many of the approximately 15.5 million Americans with coronary heart disease will receive new advice regarding whether and how long to take aspirin combined with another blood-thinning antiplatelet to prevent clotting under updated guidelines released by the American College of Cardiology (ACC) and…
The FDA has issued a complete response letter (CRL) in reply to a new drug application (NDA) for calcifediol modified-release capsules (Rayaldee, Opko Health) as a treatment for secondary hyperparathyroidism (SHPT) in patients with stage-3 or -4 chronic kidney disease (CKD) and vitamin D insufficiency.…
Promising results from a phase 2 study of AC6 gene transfer for the treatment of patients with heart failure and reduced ejection fraction have been published in JAMA Cardiology. The findings indicate that, through one-time administration, AC6 gene transfer safely increased heart function beyond optimal…
In response to an epidemic of opiate addiction, hospitals in northern North Jersey are substituting powerful pain medications with a variety of alternatives to prevent patients from getting hooked, according to a report posted on the NorthJersey.com website. Patterns of prescribing are changing for…
Eight out of ten pain patients feel hospital staff members have not been adequately trained in pain management, and more than half rate the quality of their pain care in hospitals as poor or very poor, according to a new survey from Pain News Network . More than 1,250 acute and chronic pain patients…
The FDA has approved a supplemental new drug application for Stiolto Respimat (tiotropium bromide/olodaterol inhalation spray, Boehringer Ingelheim) that adds data showing improvement in health-related quality of life among patients with chronic obstructive pulmonary disease (COPD) to the product labelling.…
Scientists at the Icahn School of Medicine at Mount Sinai compared basic blood tests run by commercial laboratories and found that the testing service and the time of collection significantly influenced results. Given that lab tests are used to help decide everything from disease diagnosis to whether…
The FDA has issued a complete response letter (CRL) in reply to a supplemental new drug application requesting permission to include new data in the clinical trials section of the U.S. label of vortioxetine (Brintellix, Takeda/Lundbeck) for treating certain aspects of cognitive dysfunction in adults…
A new analysis of the prehistoric origin of malaria suggests that it evolved in insects at least 100 million years ago, and that the first vertebrate hosts of the disease were probably reptiles, which at that time would have included dinosaurs, according to a report from Oregon State University (OSU).…
The Manhattan U.S. Attorney has asked Novartis AG to provide records of approximately 80,000 “sham” events in which the government says doctors were wined and dined so they would prescribe the company’s cardiovascular drugs. The Swiss drug maker and the U.S. Attorney’s office are engaged in…
When California’s aid-in-dying law takes effect this June, terminally ill patients who decide to end their lives could be faced with a hefty bill for the lethal drug secobarbital (Seconal). It retails for more than $3,000. Last year, the drug’s manufacturer, Valeant Pharmaceuticals, doubled the…
The Centers for Disease Control and Prevention (CDC) has issued new guidance and information to prevent Zika virus transmission and its health effects. The new information includes updated interim guidance for healthcare professionals for counseling patients about pregnancy planning and the timing of…
The FDA has denied Eagle Pharmaceuticals’ request for seven years of orphan drug exclusivity in the U.S. for Bendeka, a liquid, low-volume (50 mL), 10-minute infusion formulation of bendamustine hydrochloride. Bendeka was approved in December 2015 for the treatment of patients with chronic lymphocytic…

Pages

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA